In this episode, the late John Routt Reigart, MD, FAAP, discusses generic and biosimilar prescribing in children and adolescents. David Hill, MD, FAAP, and Joanna Parga-Belinkie, MD, FAAP, also speak with Christina Rostad, MD, FAAP, about the use of maternal vaccinations and monoclonal antibodies for the prevention of RSV.
Subscribe Now
Follow Pediatrics On Call
Guests
John Routt Reigart, MD, FAAP
Guest
The late Dr. John Routt Reigart was a pediatrician and professor emeritus of pediatrics at the Medical University of South Carolina. He was a former president of the South Carolina chapter of the AAP and a chair of the AAP Committee on Drugs. Dr. Reigart was an expert in pediatric toxicology, lead poisoning and pesticides, having led clinical trials and research since 1971. He also served in the U.S. Navy. Throughout his career, Dr. Reigart provided his expertise to numerous committees, boards and organizations dedicated to children’s health and testified before Congress on the issue of pesticides in food.
Christina A. Rostad, MD, FAAP
Guest
Dr. Christina A. Rostad is an associate professor of pediatrics and an attending physician in pediatric infectious diseases at Emory University School of Medicine and Children’s Healthcare of Atlanta. She directs the Emory Children’s Center – Vaccine Research Clinic (ECC-VRC), where she leads a multi-disciplinary research group that performs vaccine clinical trials and infectious disease translational studies for children and adults. The overarching goal of her research is to protect the health and well-being of children by better defining the burden of infectious diseases and evaluating the safety and effectiveness of vaccines and treatments.
Resources
Generic and Biosimilar Prescribing in Children and Adolescents: Policy Statement
Generic and Biosimilar Prescribing in Children and Adolescents: Technical Report
Conflict of Interest Disclosure:
Dr. Rostad has received institutional research support from Pfizer Inc., Sanofi Pasteur, Janssen, ModernaTX, Inc., Merck & Co., Inc., Novavax, and from the Centers for Disease Control and Prevention and the National Institutes of Health. She is coinventor of patented RSV vaccine technology, which has been licensed to Meissa Vaccines, Inc.
Music Credits:
"Steadfast" by Blue Dot Sessions at www.sessions.blue
Theme music composed by Matthew Simonson at Foundsound.media
*The views expressed in this podcast are those of the guests and not necessarily those of the American Academy of Pediatrics.